InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Whiting Samuel, Directeur Médical. Director active across 2 companies, notably Millendo Therapeutics, Inc.. Cumulatively, 4 disclosures have been logged. Total volume traded: €14k. The latest transaction was filed on 6 January 2022 — Acquisition. Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
€7,2201,700 shares@ €4.247100.0% of flow
Common Stock
SEC:0001209191-22-002753·
Ideal exit: 3 Oct 2022 (T+270)
€7,2201,700 shares@ €4.2470.027% mcap50.0% of flow
Common Stock
SEC:0001209191-22-002753:0·
Ideal exit: 3 Oct 2022 (T+270)
201 shares
Common Stock
SEC:0001140361-21-022931·
201 shares
Common Stock
SEC:0001140361-21-022931:0·
4 of 4 declarations
About Whiting Samuel
Whiting Samuel is the Chief Medical Officer at Millendo Therapeutics, Inc. and Tempest Therapeutics, Inc. In this role, he is responsible for the medical strategy and research initiatives of the companies. His expertise in the medical field allows him to lead innovative projects aimed at improving treatments for patients. He plays a key role in the development of new therapies.
